Cargando…
Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities
BACKGROUND: The elimination of blinding trachoma focuses on controlling Chlamydia trachomatis infection through mass antibiotic treatment and measures to limit transmission. As the prevalence of disease declines, uncertainty increases over the most effective strategy for treatment. There are little...
Autores principales: | Burton, Matthew J., Holland, Martin J., Makalo, Pateh, Aryee, Esther A. N., Sillah, Ansumana, Cohuet, Sandra, Natividad, Angels, Alexander, Neal D. E., Mabey, David C. W., Bailey, Robin L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950148/ https://www.ncbi.nlm.nih.gov/pubmed/20957147 http://dx.doi.org/10.1371/journal.pntd.0000835 |
Ejemplares similares
-
Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009) -
Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015) -
Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019) -
Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013) -
Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular
infection: a genome wide association study
por: Roberts, Chrissy h., et al.
Publicado: (2015)